序号 |
标题 |
次数 |
作者 |
发布时间 |
86761 |
CAS:753421-63-5 4-Aminobutyl-DOTA |
84 |
zyl |
2024-11-22 |
86762 |
DOTA-(t-Butyl)3-PEG-azide |
84 |
wyh |
2024-11-22 |
86763 |
CAS:2126179-28-8 Ho-p-SCN-Bn-DOTA |
79 |
zyl |
2024-11-22 |
86764 |
LLP2A-DOTA-PEG(5000) 齐岳供应 |
112 |
zcy |
2024-11-22 |
86765 |
DOTA-TAT(48-60)的基本结构 |
131 |
wyh |
2024-11-22 |
86766 |
Maleimido-mono-amide-DOTA-tris (t-Bu ester);1613382-10-7 |
131 |
wyh |
2024-11-22 |
86767 |
Lu-DOTA-TATE 镥-DOTA-奥曲肽 |
110 |
zcy |
2024-11-22 |
86768 |
Fmoc-L-Lys-mono-amide-DOTA-tris(t-Bu ester) ;479081-06-6 |
103 |
wyh |
2024-11-22 |
86769 |
罗丹明B,1-O-丙炔基-2,3,4,6-四-O-乙酰基-β-D-葡萄糖苷 |
94 |
WYQ |
2024-11-22 |
86770 |
1-(1,3-二苯基-2-丙炔基)-哌啶,1-(1,3-Diphenyl-2-propynyl)-piperidine。 |
97 |
WYQ |
2024-11-22 |
86771 |
七肽Z-GGRDOTA ;Cbz-Gly-Gly-Arg-Asp-Orn-Thr-Ala-COOH |
105 |
wyh |
2024-11-22 |
86772 |
(S)-5-氯-α-环丙炔基-2-氨基-α-三氟甲基苯甲醇 |
125 |
WYQ |
2024-11-22 |
86773 |
Ho-p-SCN-Bn-DOTA;2126179-28-8 |
105 |
wyh |
2024-11-22 |
86774 |
3-碘-2-丙炔基丁基氨基甲酸丁酯 |
84 |
WYQ |
2024-11-22 |
86775 |
单-6-(4-甲基丙烯酸丙炔基酯-1,2,3-三氮唑)-环糊精 |
82 |
WYQ |
2024-11-22 |
86776 |
DOTA-三(酸) - 酰胺-DPEG(R)24-酰氨基-DPEG(R)24-DSPE |
84 |
zyl |
2024-11-22 |
86777 |
N-[4-氯-2-氯-2-氟-5-[1-甲基2-丙炔基)氧]苯基]-3,4,5,6-四氢酞酰亚胺 |
118 |
WYQ |
2024-11-22 |
86778 |
磷脂-DOTA大环配体及其衍生物,DOTA-DSPE/DOTA-DPG |
124 |
kx |
2024-11-22 |
86779 |
Ho-p-SCN-Bn-DOTA;2126179-28-8 |
80 |
wyh |
2024-11-22 |
86780 |
DOTA-C-糖基双功能螯合剂 DOTA-C-glyco-c(RGDfC) |
90 |
zcy |
2024-11-22 |
86781 |
BCN-PEG-DOTA |
80 |
kx |
2024-11-22 |
86782 |
DOTA-SST DOTA结合的生长抑素受体靶向肽SST |
116 |
zcy |
2024-11-22 |
86783 |
DOTA-ADIBO |
136 |
wyh |
2024-11-22 |
86784 |
177943-89-4,DOTA和奥曲肽偶联双功能螯合配体 |
95 |
kx |
2024-11-22 |
86785 |
DOTA-TRIS(TBE) - 酰胺基DPEG(R)11-马来酰亚胺 |
104 |
zyl |
2024-11-22 |
86786 |
DOTA-Ala-Ala-COOH ; DOTA-丙氨酸-丙氨酸-羧酸 |
103 |
wyh |
2024-11-22 |
86787 |
DOTA(Gd)-ANADYWR 整合素α6靶向磁共振(MR)探针 |
106 |
zcy |
2024-11-22 |
86788 |
181065-46-3,p-NH2-Bn-DOTA |
86 |
kx |
2024-11-22 |
86789 |
CAS:177943-89-4 DOTATATE acetate |
101 |
zyl |
2024-11-22 |
86790 |
Dota-Eb-Tate DOTA标记生长抑素类似物 |
89 |
zcy |
2024-11-22 |
86791 |
DOTA-tri-t-Bu-ester,DOTA-tris(t-Bu ester);DOTA-三叔丁酯 |
112 |
wyh |
2024-11-22 |
86792 |
817562-90-6,(R)-tert-Bu4-DOTAGA,(R)-DOTAGA-四叔丁酯 |
91 |
kx |
2024-11-22 |
86793 |
CAS:137076-54-1 三叔丁基1,4,7,10-四氮杂环十二烷-1,4,7,10-四乙酸 |
101 |
zyl |
2024-11-22 |
86794 |
3-碘-2-丙炔基丁基氨基甲酸丁酯 |
77 |
WYQ |
2024-11-22 |
86795 |
HPPH-17偶联水溶性Gd(III)-氨乙基酰胺基-DOTA |
112 |
zcy |
2024-11-22 |
86796 |
单-6-(4-甲基丙烯酸丙炔基酯-1,2,3-三氮唑)-环糊精 |
104 |
WYQ |
2024-11-22 |
86797 |
DOTA-CH2-Ph-azide(HCl salt) |
72 |
wyh |
2024-11-22 |
86798 |
204318-14-9,Edotreotide ,DOTA-TOC,DOTA-(酪氨酸3)-奥曲肽 |
98 |
kx |
2024-11-22 |
86799 |
CAS:911197-00-7 Propargyl-DOTA-tris(tBu)ester |
101 |
zyl |
2024-11-22 |
86800 |
罗丹明B,1-O-丙炔基-2,3,4,6-四-O-乙酰基-β-D-葡萄糖苷 |
114 |
WYQ |
2024-11-22 |
86801 |
DOTA-UAMC1110 DOTA螯合剂偶联FAP抑制剂(UAMC1110) |
139 |
zcy |
2024-11-22 |
86802 |
1-(1,3-二苯基-2-丙炔基)-哌啶 |
104 |
WYQ |
2024-11-22 |
86803 |
p-SCN-Bn-DOTA;127985-74-4 |
94 |
wyh |
2024-11-22 |
86804 |
(S)-5-氯-α-环丙炔基-2-氨基-α-三氟甲基苯甲醇 |
129 |
WYQ |
2024-11-22 |
86805 |
DOTA-NHS ester,四氮杂环十二烷四乙酸-琥珀酰亚胺酯 |
104 |
kx |
2024-11-22 |